2023
Cost of introducing and delivering malaria vaccine (RTS,S/AS01E) in areas of seasonal malaria transmission, Mali and Burkina Faso
Diawara H, Bocoum F, Dicko A, Levin A, Lee C, Koita F, Ouédraogo J, Guissou R, Yabré S, Traoré S, Morgan W, Pecenka C, Baral R. Cost of introducing and delivering malaria vaccine (RTS,S/AS01E) in areas of seasonal malaria transmission, Mali and Burkina Faso. BMJ Global Health 2023, 8: e011316. PMID: 37068848, PMCID: PMC10111920, DOI: 10.1136/bmjgh-2022-011316.Peer-Reviewed Original ResearchConceptsVaccine deliverySeasonal vaccinationMalaria vaccineMalaria transmissionSeasonal malaria transmissionRoutine Expanded ProgrammeResource use dataRoutine EPINew vaccine introductionSeasonal malariaVaccine introductionMain cost driversHealth facilitiesExpanded ProgrammeVaccine priceVaccine rolloutMass campaignsService deliveryYoung childrenVaccinationCost consequencesBurkina FasoFinancial costsVaccineDelivery approach
2016
Cost-Consequences and Health Outcomes of Emtricitabine and Tenofovir Alafenamide (FTC/TAF): A Novel Two-Drug, Fixed-Dose Combination for Human Immunodeficiency Virus (HIV) Patients
Altice F, Dejesus E. Cost-Consequences and Health Outcomes of Emtricitabine and Tenofovir Alafenamide (FTC/TAF): A Novel Two-Drug, Fixed-Dose Combination for Human Immunodeficiency Virus (HIV) Patients. Open Forum Infectious Diseases 2016, 3: 495. DOI: 10.1093/ofid/ofw172.358.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply